Authors:
SANCHEZCORTES E
GAYTANMARTINEZ J
MATEOSGARCIA E
VELAOJEDA J
TRIPPVILLANUEVA F
ROJASCASTANEDA MI
RIOSMARTINEZ S
FUENTESALLENDE JL
GONZALESLLAVEN J
Citation: E. Sanchezcortes et al., PENICILLIUM SP INFECTION AFTER CHEMOTHERAPY FOR LEUKEMIA AND BONE-MARROW TRANSPLANTATION (BMT) - REPORT OF 3 CASES, Blood, 90(10), 1997, pp. 4433-4433
Authors:
VELAOJEDA J
TRIPPVILLANUEVA F
SANCHEZCORTES E
AYALASANCHEZ M
GONZALEZLLAVEN J
Citation: J. Velaojeda et al., 2ND BONE-MARROW TRANSPLANT (2BMT) AND DONOR LEUKOCYTE INFUSIONS (DLI)TO TREAT RELAPSE OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 4479-4479
Authors:
VELAOJEDA J
TRIPPVILLANUEVA F
SANCHEZCORTES E
GONZALEZLLAVEN J
Citation: J. Velaojeda et al., TOPICAL ORAL GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FOR THE TREATMENT OF MUCOSITIS AFTER BONE-MARROW TRANSPLANTATION, Blood, 88(10), 1996, pp. 3739-3739
Authors:
TRIPPVILLANUEVA F
GOMEZ L
DIAZLEON L
ZARZOSAMORALES M
GONZALEZLLAVEN J
BAHENA P
Citation: F. Trippvillanueva et al., REGIONAL INTRARTERIAL CHEMOTHERAPY (CT) FOR SINONASAL ANGIOCENTRIC REFRACTORY LYMPHOMA, Blood, 86(10), 1995, pp. 3285-3285
Authors:
VELAOJEDA J
TRIPPVILLANUEVA F
SANCHEZCORTES E
ZARZOSA ME
GARCIAMANZANO A
GONZALEZLLAVEN J
Citation: J. Velaojeda et al., PENTOXIFYLLINE (PTX) IN THE PREVENTION OF HEPATIC VENO-OCLUSIVE DISEASE (VOD) AFTER BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 3872-3872
Authors:
GONZALEZLLAVEN J
SANCHEZCORTEZ E
VELAOJEDA J
TRIPPVILLANUEVA F
Citation: J. Gonzalezllaven et al., LONG-TERM FOLLOW-UP OF 24 PATIENTS (PT) WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH ATRA AND CONSOLIDATION CHEMOTHERAPY (QT), Blood, 84(10), 1994, pp. 10000619-10000619
Authors:
VELAOJEDA J
GARCIARUIZESPARZA MA
VAZQUEZ V
SANCHEZCORTES E
TRIPPVILLANUEVA F
GONZALEZLLAVEN J
Citation: J. Velaojeda et al., CHEMOTHERAPY AND INTERFERON ALFA-2B IN NEWLY-DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000659-10000659